Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Tumor Biology
Published in: Tumor Biology 5/2014

01-05-2014 | Editorial

Comment on Fu et al.: A systematic review of p53 as a biomarker of survival in patients with osteosarcoma

Authors: Jinjun Chen, Lanlan Ma, Guanghui Wei

Published in: Tumor Biology | Issue 5/2014

Login to get access

Excerpt

To the Editor: …
Literature
1.
2.
Ye ZM, Li WX, Fan SW, Yang DS, Tao HM. Expression of p53 protein and proliferating cell nuclear antigen (PCNA) in osteosarcoma and its prognostic significance. Zhejiang Med J. 2000;22:65–7. article in Chinese.
3.
Zhang L, Yang ZY, Tang RY, Mei J, Ai ZS. The relationship with the protein expression of p53, pTEN and the three-year survival ratios in osteosarcoma patients. J Pract Radiol. 2003;19:673–6. article in Chinese.
4.
Wu X, Chen ZR, Zhang GJ. Apoptosis-related gene expression and its clinical significance of human osteosarcoma. Zhonghua Zhong Liu Za Zhi. 2004;26:678–81. article in Chinese.PubMed
5.
Bao Y, Li HP, Fan R, Jiang C. Expression of p53 protein in osteosarcoma and its significance. Acta Acad Med CPAPF. 2006;15:230–1. article in Chinese.
6.
Zhang SQ, Xiao DM, Zhu YH, Guan H, Li W, Tan JF. Protein expression of p53 in osteosarcoma and the correlation with clinical features and prognosis. J Mod Oncol. 2011;19:145–6. article in Chinese.
Metadata
Title
Comment on Fu et al.: A systematic review of p53 as a biomarker of survival in patients with osteosarcoma
Authors
Jinjun Chen
Lanlan Ma
Guanghui Wei
Publication date
01-05-2014
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 5/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-1541-1

Other articles of this Issue 5/2014

Tumor Biology 5/2014 Go to the issue

Research Article

The Glu298Asp polymorphism in the NOS3 gene and the risk of prostate cancer

Research Article

An analysis of the most-cited research papers on oncology: which journals have they been published in?

Research Article

Expression profile of apoptosis-related genes potentially explains early recurrence after definitive chemoradiation in esophageal squamous cell carcinoma

Research Article

MGMT Leu84Phe gene polymorphism and lung cancer risk: a meta-analysis

Research Article

Clinicopathologic factors predicting outcomes in patients with gastrointestinal stromal tumors of the rectum and colon

Research Article

Expression and clinical significance of BIRC6 in human epithelial ovarian cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits